SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Onconova Therapeutics Inc. to Present Data Demonstrating Survival Benefit in MDS Patients Treated with Rigosertib and Phase I Data for Oral Rigosertib at the American Society of Hematology Annual Meeting